We are an early stage technology company, using artificial intelligence to tackle the cost and complexity of clinical safety and pharmacovigilance. Our vision is to help to keep patients safe by simplifying the detection of adverse events from drug development to post-market. The first product to be developed is aimed at Medical Literature